Lack of association between interleukin-1 receptor antagonist protein gene polymorphism and bone mineral density in Hungarian postmenopausal women

Bone

Volumn 27, Issue 4, 2000, Pages 559-562

  Bajnok, É ^a   Takacs I ^a   Vargha, P ^a   Speer, G ^a   Nagy, Z ^a   Lakatos, P ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Bone mineral density (BMD); Interleukin I receptor antagonist protein (IL 1RN); Osteoporosis; Polymorphism

Indexed keywords

BIOCHEMICAL MARKER; BONE MINERAL; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ADULT; ALLELE; ARTICLE; BONE MASS; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENOTYPE; HUMAN; HUMAN EXPERIMENT; HUNGARY; NORMAL HUMAN; POSTMENOPAUSE OSTEOPOROSIS; VARIABLE NUMBER OF TANDEM REPEAT;

ADULT; AGED; BONE DENSITY; FEMALE; GENOTYPE; HUMAN; MIDDLE AGE; MINISATELLITE REPEATS; POLYMORPHISM (GENETICS); POSTMENOPAUSE; SIALOGLYCOPROTEINS; SUPPORT, NON-U.S. GOV'T;

EID: 0033800141     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(00)00360-4     Document Type: Article

References (44)

1. Cytokines and T-lymphocyte subsets in healthy postmenopausal women; Estrogen retards bone loss without affecting the release of IL-1 or IL-1ra
2. The heritability of bone mineral density, ultrasound of the calcaneus and hip axis length; A study of postmenopausal twins
3. Interleukin-1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus erythematosus
4. Interleukin-1 receptor antagonist allele (IL1RN*2) associated with nephropathy in diabetes mellitus
5. Association of Graves' disease with an allele of the interleukin-1 receptor antagonist gene
6. Cytokine production by normal human monocytes; Inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism
7. Polymorphism within the second intron of the IL-1 receptor antagonist gene in patients with hematopoietic malignancies
8. Interleukin-1 and its receptor
9. Blocking IL-1; Interleukin 1 receptor antagonist in vivo and in vitro
10. IL-1 receptor antagonist genotype is associated with low bone mineral density in postmenopausal osteoporosis
11. Association and sib pair linkage analysis studies between BMD and the vitamin D receptor (VDR)
12. Segregation analysis and variance components analysis of bone mineral density in healthy families
13. Interleukin-1 receptor antagonist inhibits the hypercalcemia mediated by interleukin-1
14. Genetic and environmental correlations between bone formation and bone mineral density; A twin study
15. The interleukin-1 receptor antagonist gene shows no allelic association with three autoimmune diseases
16. Resistance to human cytomegalovirus infection may be influenced by genetic polymorphisms of the tumour necrosis factor-alpha and interleukin-1 receptor antagonist genes
17. IL-1 receptor antagonist (IL-1Ra) plasma levels are co-ordinately regulated by both IL-1Ra and IL-1β genes
18. Allelic variation at the interleukin-1 receptor antagonist gene is associated with early postmenopausal bone loss at the spine
19. Genetic factors in bone turnover
20. Circulating cytokine levels in osteoporotic and normal women
21. Persistent bone-sparing effect of interleukin-1 receptor antagonist; A hypothesis on the role of IL-1 in ovariectomy-induced bone loss
22. Osteoporotic fractures are associated with an 86-base pair repeat polymorphism in the interleukin-1 receptor antagonist gene but not with polymorphism in the interleukin-1 beta gene
23. Cloning and chromosome mapping of the human interleukin-1 receptor antagonist gene
24. Prediction of bone density from vitamin D receptor alleles [letter to the editor]
25. Lack of association of Graves' disease with the A2 allele of the interleukin-1 receptor antagonist gene in a white European population
26. Polymorphisms of the interleukin-6 gene are associated with bone mineral density
27. Monocytic secretion of interleukin-1 receptor antagonist in normal and osteoporotic women; Effects of menopause and estrogen/progesterone therapy
28. Genetic determinants of bone mass in adults. A twin study
29. Analysis of gene expression in human bone biopsies by polymerase chain reaction; Evidence for enhanced cytokine expression in postmenopausal osteoporosis
30. Effects of estrogen therapy of postmenopausal women on cytokines measured in peripheral blood
31. Association between serum insulin growth factor-I (IGF-I) and a simple sequence repeat in IGF-I gene; Implications for genetic studies of bone mineral density
32. Genetic markers may predict disease behavior in patients with ulcerativ colitis
33. Infusions of recombinant human interleukins-1 alpha and 1 beta cause hypercalcemia in normal mice
34. Association of estrogen receptor dinucleotide repeat polymorphism with osteoporosis
35. Genetic determinants of bone mass in adult women; A reevaluation of the twin model and the potential importance of gene interaction on heritability estimates
36. Sibling pair linkage and association studies between bone mineral density and the insulin-like growth factor
37. Correlation of a polymorphism in the interleukin-1 receptor antagonist gene with hepatic fibrosis in Japanese alcoholics
38. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-by tandem repeat
39. Use of an in vivo model to determine the effects of interleukin-1 on cells at different stages in the osteoclast lineage
40. Lack of association between estrogen receptor genotypes and bone mineral density, fracture history, or muscle strength in elderly women
41. Highly polymorphic locus in human DNA